Skip to content
value.today
Sensus Healthcare, Inc. logo

Sensus Healthcare, Inc.

SRTS
$49 Mmarket cap on Oct 1, 2026+17.2% since Jan 2024
Compare
World rank
#21,331
Revenue
$27 M
For year ending December-2025
Net income
$-8 M
-28.1% margin
SEC filing
Employees
60
As of December 31, 2025
SEC filing

Sensus Healthcare, Inc. in brief

Sensus Healthcare, Inc. is a listed company in the Medical Devices industry, based in Boca Raton, Florida, USA. Its market value was $49 M on 1 October 2026, which makes it the 21,331st largest listed company in the world and the 3,862nd largest in the USA on this site. In the year to December 2025 it had sales of $27 M and a net loss of $8 M. It employs about 60 people and Joseph C. Sardano is its chief executive. Its largest product and service lines by sales in 2025 were Service Revenue (13%) and Product Revenue (6%). By market, the largest shares of its 2025 sales came from USA (92%) and China (7%). Its shares trade under the symbol SRTS (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Sensus Healthcare, Inc.

Sensus Healthcare, Inc. is a medical device company committed to providing highly effective, non-invasive treatments for non-melanoma skin cancer (NMSC) and post-surgical keloid scar prevention. The Company uses a proprietary low-energy X-ray technology known as superficial radiation therapy, which is based on decades of dedicated research and development, and has successfully incorporated SRT into a portfolio of treatment devices: the SRT-100TM, SRT-100+TM and SRT-100 VisionTM. To date, SRT technology has been used to effectively and safely treat oncological and non-oncological skin conditions of close to one-million patients around the world.

From the company's annual report filed with the US SEC: read the report

Sensus Healthcare, Inc. timeline

5 events, 2010–2022
  1. 2010
  2. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  3. 2015
  4. ✎
    Renamed Sensus Healthcare, Inc.
    Formerly Sensus Healthcare, LLC.
  5. 2016
  6. 🔔
    · approximate
    Initial public offering on Nasdaq
  7. 2022
  8. 💰
    Record revenue of $45 million
    FY2022, the highest of the 8 years on record.
  9. 💰
    Record net income of $24 million
    FY2022, the highest profit of the 4 years on record.

Events of Sensus Healthcare, Inc. from SEC EDGAR, the company record and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$37 M$73 M$110 M$147 M2020202120222023202420252026

World rank over time

▼ down 263 places since 2020
2020-01-01: #21137#21,13720202021-01-01: #19821#19,82120212022-01-07: #21216#21,21620222022-12-25: #20897#20,89720222023-07-30: #25390#25,39020232024-01-05: #25760#25,76020242026-03-08: #10493#10,49320262026-08-01: #19608#19,60820262026-10-01: #21400#21,4002026

Rank in USA: #4,032 (Jan 2020) · #3,942 (Jan 2021) · #4,171 (Jan 2022) · #4,152 (Dec 2022) · #4,763 (Jul 2023) · #4,146 (Jan 2024) · #2,048 (Mar 2026) · #3,753 (Aug 2026) · #3,843 (Oct 2026)

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
n/m (loss)
Price / sales (TTM)
2.8×
Price / book
1.0×
Free cash flow yield
0.7%
Net margin (TTM)
-88.5%
Operating margin
-37.5%
Return on equity
-32.2%
Liabilities / assets
9.3%
Revenue growth
-34.3%
R&D / revenue
28.3%
Revenue per employee
$458 K
Profit per employee
$-129 K

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Dec 2018: revenue $26M, net income $-2M$26MFY18Fiscal year ending Dec 2019: revenue $27M, net income $-2M$27MFY19Fiscal year ending Dec 2020: revenue $10M, net income $-7M$10MFY20Fiscal year ending Dec 2021: revenue $27M, net income $4M$27MFY21Fiscal year ending Dec 2022: revenue $45M, net income $24M$45MFY22Fiscal year ending Dec 2023: revenue $24M, net income $0M$24MFY23Fiscal year ending Dec 2024: revenue $42M, net income $7M$42MFY24Fiscal year ending Dec 2025: revenue $27M, net income $-8M$27MFY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025$27M-34.3%$-10M$-8M-28.1%
Dec 2024$42M+71.4%$8M$7M15.9%
Dec 2023$24M-45.2%$-0M$0M2.0%
Dec 2022$45M+64.7%$15M$24M54.4%
Dec 2021$27M+182.3%$4M$4M15.2%
Dec 2020$10M-64.9%$-8M$-7M-71.4%
Dec 2019$27M+3.1%$-2M$-2M-6.2%
Dec 2018$26M—$-2M$-2M-7.6%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$1M$0M$0M$-0.47—
Dec 2024$-1M$0M$-1M$0.41—
Dec 2023$-2M$0M$-2M$0.03—
Dec 2022$-1M$0M$-2M$1.46—
Dec 2021$-0M$0M$-0M$0.25—
Dec 2020$-0M$0M$-1M$-0.42—
Dec 2019$-2M$0M$-3M$-0.10—
Dec 2018$-9M$1M$-9M$-0.14—

Quarterly results

USD · three months to · source: SEC filings
Revenue, trailing 12 months
$18M
Net income, trailing 12 months
$-15M
RevenueNet income
Three months to Dec 2024 (from the annual report): revenue $13M, net income $2M$13MDec ’24Three months to Mar 2025: revenue $8M, net income $-3M$8MMar ’25Three months to Jun 2025: revenue $7M, net income $-1M$7MJun ’25Three months to Sep 2025: revenue $7M, net income $-1M$7MSep ’25Three months to Dec 2025 (from the annual report): revenue $5M, net income $-3M$5MDec ’25Three months to Mar 2026: revenue $3M, net income $-3M$3MMar ’26Three months to Jun 2026: revenue $2M, net income $-9M$2MJun ’26Three months to Sep 2026: revenue $6M, net income $-1M$6MSep ’26

Latest quarter to Sep 2026: revenue $6M (-12.8% on a year earlier), net income $-1M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Jun 2026.

SEC filings

Official filings of Sensus Healthcare, Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
$27 M
Operating income
$-10 M
Net income
$-8 M

For year ending December-2025 · source: SEC filing

Balance sheet

Total assets
$53 M
Total liabilities
$5 M
Total equity
$48 M

As of December-2025

Top 37 institutional investors in Sensus Healthcare, Inc.#

As of Sep 30, 2026
37 institutions held 3.6 M shares (about 21.9% of the shares outstanding) on Sep 30, 2026. The ten largest hold 17.8%. Source: SEC Form 13F filings, filed through Nov 17, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in Sensus Healthcare, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1Pacific Ridge Capital Partners, LLC784,339-5,336 (-0.68%)4.76%$2 MNov 12, 2026
2Vanguard Capital Management LLC660,4020 (0.00%)4.01%$2 MNov 13, 2026
3Dimensional Fund Advisors LP301,073-15,048 (-4.76%)1.83%$1 MNov 4, 2026
4Divisadero Street Capital Management, LP278,4850 (0.00%)1.69%$1 MNov 16, 2026
5Renaissance Technologies LLC229,634-12,700 (-5.24%)1.39%$1 MNov 12, 2026
6Geode Capital Management, LLC154,1520 (0.00%)0.94%$0 MNov 6, 2026
7Greenline Wealth Management LLC148,774+20,000 (+15.53%)0.90%$0 MNov 10, 2026
8UBS Group AG143,146-9,427 (-6.18%)0.87%$0 MNov 10, 2026
9North Star Investment Management Corp.125,5860 (0.00%)0.76%$0 MOct 27, 2026
10Bank of New York Mellon Corp101,646+1,236 (+1.23%)0.62%$0 MNov 5, 2026
11Mindset Wealth Management, LLC86,000+33,900 (+65.07%)0.52%$0 MOct 19, 2026
12BlackRock, Inc.81,420-2,135 (-2.56%)0.49%$0 MNov 13, 2026
13Vanguard Fiduciary Trust Co76,2890 (0.00%)0.46%$0 MNov 13, 2026
14Allworth Financial LP69,880New0.42%$0 MNov 17, 2026
15State Street Corp69,2520 (0.00%)0.42%$0 MNov 12, 2026
16Ingalls & Snyder LLC55,0000 (0.00%)0.33%$0 MNov 12, 2026
17Janney Montgomery Scott LLC40,5760 (0.00%)0.25%$0 MNov 12, 2026
18Chapin Davis, Inc.36,000+10,000 (+38.46%)0.22%$0 MOct 9, 2026
19Citadel Advisors LLC30,391New0.18%$0 MNov 16, 2026
20Northern Trust Corp28,1870 (0.00%)0.17%$0 MNov 16, 2026
21American Century Companies Inc21,2720 (0.00%)0.13%$0 MNov 12, 2026
22IMC-Chicago, LLC17,742New0.11%$0 MNov 5, 2026
23Ashton Thomas Private Wealth, LLC16,828+521 (+3.19%)0.10%$0 MNov 3, 2026
24Cetera Investment Advisers16,000New0.10%$0 MNov 13, 2026
25StoneX Group Inc.13,151-227 (-1.70%)0.08%$0 MNov 3, 2026
Show all 37: investors 26 to 37
Institutional investors 26 to 37 in Sensus Healthcare, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
26Rockefeller Capital Management L.P.7,0000 (0.00%)0.04%$0 MNov 13, 2026
27Vanguard Global Advisers, LLC4,9610 (0.00%)0.03%$0 MNov 13, 2026
28Morgan Stanley4,2670 (0.00%)0.03%$0 MNov 13, 2026
29Barclays PLC3,440+654 (+23.47%)0.02%$0 MNov 6, 2026
30Jones Financial Companies Lllp1,2750 (0.00%)0.01%$0 MNov 13, 2026
31Osaic Holdings, Inc.1,1960 (0.00%)0.01%$0 MNov 12, 2026
32Farther Finance Advisors, LLC1,0810 (0.00%)0.01%$0 MOct 8, 2026
33Tower Research Capital LLC (TRC)997-27 (-2.64%)0.01%$0 MNov 16, 2026
34Larson Financial Group LLC8000 (0.00%)0.00%$0 MNov 5, 2026
35Nuveen, LLC418New0.00%$0 MNov 10, 2026
36FMR LLC155+6 (+4.03%)0.00%$0 MNov 10, 2026
37SBI Securities Co., Ltd.130 (0.00%)0.00%$0 MOct 22, 2026

Mutual funds holding Sensus Healthcare, Inc.#

29 funds hold shares worth $5 M (about 9.6% of the company). Since their previous reports 5 added shares and 3 sold, selling $0 M net.
Mutual funds holding Sensus Healthcare, Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc.494,131$1 M3.0%<0.01%no changeJun 30, 2026
🇺🇸 Adara Smaller Companies FundRBB Fund, Inc.310,940$1 M1.9%0.12%no changeMay 31, 2026
🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc.154,670$0 M0.94%<0.01%+8.5%Jun 30, 2026
🇺🇸 North Star Micro Cap FundNorth Star Investment Management Corp.125,586$0 M0.76%0.21%no changeMay 31, 2026
🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC77,130$0 M0.47%<0.01%+3.5%May 31, 2026
🇺🇸 U.S. Small Cap PortfolioDimensional Fund Advisors LP75,124$0 M0.46%<0.01%no changeJul 31, 2026
🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors46,361$0 M0.28%<0.01%+36%Jun 30, 2026
🇺🇸 U.S. Small Cap Value PortfolioDimensional Fund Advisors LP45,206$0 M0.27%<0.01%−21%Jul 31, 2026
🇺🇸 Dimensional U.S. Small Cap ETFDimensional Fund Advisors LP29,133$0 M0.18%<0.01%−48%Jul 31, 2026
🇺🇸 Dimensional US Small Cap Value ETFDimensional Fund Advisors LP28,566$0 M0.17%<0.01%−58%Jul 31, 2026
🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC24,723$0 M0.15%<0.01%no changeMay 31, 2026
🇺🇸 U.S. Core Equity 2 PortfolioDimensional Fund Advisors LP22,487$0 M0.14%<0.01%no changeJul 31, 2026
🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC20,910$0 M0.13%<0.01%+6.5%May 31, 2026
🇺🇸 Dimensional U.S. Core Equity 2 ETFDimensional Fund Advisors LP21,580$0 M0.13%<0.01%no changeJul 31, 2026
🇺🇸 Avantis U.S. Small Cap Equity ETFAmerican Century ETF Trust20,030$0 M0.12%<0.01%no changeMay 31, 2026
🇺🇸 U.S. Micro Cap PortfolioDimensional Fund Advisors LP13,502$0 M0.08%<0.01%no changeJul 31, 2026
🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc.11,601$0 M0.07%<0.01%no changeJun 30, 2026
🇺🇸 U.S. Core Equity 1 PortfolioDimensional Fund Advisors LP11,506$0 M0.07%<0.01%no changeJul 31, 2026
🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC10,687$0 M0.06%<0.01%no changeMay 31, 2026
🇺🇸 U.S. Social Core Equity 2 PortfolioDimensional Fund Advisors LP7,608$0 M0.05%<0.01%no changeJul 31, 2026
🇺🇸 U.S. Sustainability Core 1 PortfolioDimensional Fund Advisors LP4,620$0 M0.03%<0.01%no changeJul 31, 2026
🇺🇸 U.S. Vector Equity PortfolioDimensional Fund Advisors LP3,395$0 M0.02%<0.01%no changeJul 31, 2026
🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC3,049$0 M0.02%<0.01%+32%Jun 30, 2026
🇺🇸 Dimensional US Vector Equity ETFDimensional Fund Advisors LP3,100$0 M0.02%<0.01%no changeJul 31, 2026
🇺🇸 JNL/DFA U.S. Small Cap FundJackson National Asset Management, LLC2,400$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 Dimensional US Sustainability Core 1 ETFDimensional Fund Advisors LP2,267$0 M0.01%<0.01%no changeJul 31, 2026
🇺🇸 AST Small-Cap Equity PortfolioAST Investment Services, Inc.1,770$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 Avantis U.S. Small Cap Equity FundAmerican Century ETF Trust1,242$0 M<0.01%<0.01%no changeMay 31, 2026
🇺🇸 Dimensional US Core Equity 1 ETFDimensional Fund Advisors LP4$0 M<0.01%<0.01%no changeJul 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 29 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at Sensus Healthcare, Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$676 K
12 purchases, 2 insiders
Sold, 12 months
$0
0 sales, 0 insiders
Net, 12 months
$676 K
open market only
Insiders on file
15
since
$563 K-$123 K$0May 2024: bought $0 (0 trades), sold $123 K (2 trades)May 24Feb 2025: bought $9 K (2 trades), sold $0 (0 trades)FebAug 2025: bought $3 K (1 trades), sold $0 (0 trades)AugNov 2025: bought $148 K (5 trades), sold $0 (0 trades)NovFeb 2026: bought $8 K (1 trades), sold $0 (0 trades)FebMay 2026: bought $5 K (1 trades), sold $0 (0 trades)MayAug 2026: bought $563 K (8 trades), sold $0 (0 trades)AugNov 2026: bought $72 K (1 trades), sold $0 (0 trades)Nov
Bought (open market)Sold (open market)Hover a month for the totals
Sensus Healthcare, Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Joseph C. SardanoCHIEF EXECUTIVE OFFICER, DirectorBuy+30,000$2.404$72 K1.25 MForm 4
filed Eric SachettaDirectorBuy+27,304$3.540$97 K294,784Form 4
filed Eric SachettaDirectorBuy+37,537$3.440$129 K267,480Form 4
filed Eric SachettaDirectorBuy+10,925$3.180$35 K229,943Form 4
filed Eric SachettaDirectorBuy+9,708$3.290$32 K219,018Form 4
filed Eric SachettaDirectorBuy+34,697$3.250$113 K209,310Form 4
filed Eric SachettaDirectorBuy+7,000$3.250$23 K174,613Form 4
filed Eric SachettaDirectorBuy+24,000$3.130$75 K167,613Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: Sensus Healthcare, Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
222,266
1.4% of shares · 7.19 days to cover
Buybacks, Q4 2025
$0M
Q4 2025
Shares sold short, last 24 reportsAll stocks →

Stock splits: 241.95-for-1 split in the period to ; 241.95-for-1 split

Sensus Healthcare, Inc. share buybacks by quarter
Buybacks, quarterFiscalSpent
Q4 2025Q4 2025$0M
Q3 2025Q3 2025$0M
Q2 2025Q2 2025$0M
Q1 2025Q1 2025$0.3M
Q4 2023Q4 2023$0M
Q4 2022Q4 2022$2M
Q3 2022Q3 2022$0M

Trading halts

  • 2026-11-04 14:50 UTC, code LUDP, resumed 14:55 UTC
  • 2026-11-04 14:37 UTC, code LUDP, resumed 14:49 UTC
  • 2026-11-04 14:31 UTC, code LUDP, resumed 14:36 UTC
  • 2026-11-03 16:40 UTC, code LUDP, resumed 16:50 UTC

Fails to deliver

  • : 346 shares at $2.99
  • : 856 shares at $3.07
  • : 42 shares at $3.00
  • : 206 shares at $2.94
  • : 41 shares at $3.07

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

Sensus Healthcare, Inc. scorecard#

Passes 5 of the 22 checks that could be worked out: strongest in financial health (2 of 3), weakest in growth (0 of 6). Fiscal year 2025; market cap of Oct 1, 2026.

  • Valuation1 of 5
    • ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
    • ✓Price to book below its peers' median1.0×Price to book 1.0× against Medical Devices's median of 2.5×.
    • ✗Price to sales below its peers' median2.8×Price to sales 2.8× against Medical Devices's median of 2.4×.
    • ✗Free cash flow yield above 5%0.7%Free cash flow is 0.7% of the market value.
    • ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
    • –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
  • Growth0 of 6
    • ✗Revenue grew in the newest year-34.3%Revenue down 34.3% in fiscal 2025.
    • ✗Revenue up more than 5% a year over three years-14.9%-14.9% a year over the three years to fiscal 2025.
    • ✗Faster growth over three years than its peers' median-14.9%-14.9% a year against Medical Devices's median of 10.8% (73 companies).
    • ✗Earnings per share grew in the newest year-0.47 vs 0.41Diluted EPS -0.47 in fiscal 2025 against 0.41 the year before (report's currency).
    • ✗Net income higher than five years earlier-$8 M-$8 M in fiscal 2025 against -$7 M in 2020.
    • ✗Revenue rose in at least four of the last five years3 of 5Revenue rose in 3 of the five years to fiscal 2025.
  • Profitability0 of 5
    • ✗Profitable in the newest year-$8 MNet income -$8 M in fiscal 2025.
    • ✗Profitable in each of the last five years4 of 5Profitable in 4 of the five years to fiscal 2025.
    • ✗Operating margin above its peers' median-37.5%-37.5% against Medical Devices's median of -8.2% (86 companies).
    • ✗Return on equity above 15%-14.9%-14.9% in fiscal 2025.
    • –Return on invested capital above 10%No return on invested capital on file.
    • ✗Operating margin wider than three years earlier-37.5%-37.5% in fiscal 2025 against 33.3% in 2022.
  • Financial health2 of 3
    • ✓Short-term assets cover short-term liabilities9.7×Current ratio 9.72 at the end of fiscal 2025.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✗Cash from operations positive in each of the last three years1 of 3Positive in 1 of the three years to fiscal 2025.
    • ✓Altman Z-score outside the distress zone6.94Z-score 6.94 (safe zone) for fiscal 2025.
  • Shareholder returns2 of 3
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✓Share count up no more than 2% in a year-0.2%Diluted shares down 0.2% in fiscal 2025.
    • ✗Dividends and buybacks above 3% of the market value0.6%Dividends and buybacks were 0.6% of the market value.
    • ✓Free cash flow covers dividends and buybacks$0 MFree cash flow $0 M against $0 M paid out in fiscal 2025.

Worked out from the statements as filed (sec), the medians of Medical Devices, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2025#

Worked out from Sensus Healthcare, Inc.'s statements, beside the median of Medical Devices.

Sensus Healthcare, Inc.: main financial ratios in 2025
Ratio2025Median of peers
Operating margin-37.5%-8.2%
Net margin-28.1%-10.4%
Return on equity-14.9%-16.8%
Revenue growth, 3 years a year-14.9%10.8%
Revenue growth-34.3%10.4%
Free cash flow margin1.2%-1.9%

4of 8on the Piotroski tests of financial strength

  • Revenue fell 34.3% against the year before.
  • Net loss of $8 million.

Sensus Healthcare, Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD thousands; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Sensus Healthcare, Inc.: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021FY 2020to Dec 31, 2020FY 2019to Dec 31, 2019FY 2018to Dec 31, 2018FY 2017to Dec 31, 2017FY 2016to Dec 31, 2016
Income statement
Revenue27,48241,80724,40544,53227,0429,577r27,26326,42720,58814,811
Cost of revenue15,61517,37610,34514,90410,0544,328r9,7069,5166,7884,965
Gross profit11,86724,43114,06029,62816,9885,249r17,55716,91113,8009,846
Research and development7,7784,2163,6783,4603,4364,158r6,4186,2605,4901,824
Selling, general and administrative7,8737,1475,156———————
Selling and marketing6,5234,9785,6086,3294,8385,336r9,1038,5328,3054,915
General and administrative——5,1565,0084,5943,989r4,0054,1243,7223,469
Operating expenses22,17416,34114,44214,79712,86813,483r19,52518,91617,51710,209
Operating income−10,3078,090−38214,8314,120−8,234r−1,968−2,005−3,717−363
Interest expense and finance costs—−932−992−380r2.014r—1576922
Net interest income683932————————
Other non-operating income (expense)6839321,03413,159−1.01,398r268−176.917
Income before tax−9,6249,02265227,9904,119————−346
Income tax−1,9052,3751673,746——————
Net income attributable to shareholders−7,7196,64748524,2444,119−6,836r−1,700−2,023−3,711−346
Earnings per share, basic-0.470.410.031.470.25-0.42-0.10-0.14-0.28-0.03
Earnings per share, diluted-0.470.410.031.460.25-0.42-0.10-0.14-0.28-0.03
Shares, weighted average (basic)161616161616————
Shares, weighted average (diluted)16161617171616141312
Balance sheet
Cash and cash equivalents22,08322,05623,14825,52014,51914,907r8,100r12,48410,0855,042
Receivables6,04119,73110,64517,29912,1303,776r14,01113,1464,9583,099
Inventory14,56310,09711,8613,5011,7594,427r2,9971,6291,1711,255
Other current assets1,6831,507888660r268r2,061r1,5051,751567901
Current assets45,89256,73849,52853,24131,24525,171r34,00331,90217,88716,759
Property, plant and equipment1,9761,9974642436051,356r1,082891394433
Right-of-use (leased) assets4525817749961691,076r1,4000——
Other intangible assets———50146338r337434530627
Total assets53,03962,16553,71056,73532,24028,010r36,92533,25118,83518,947
Accounts payable3,3434,8112,7935,5210.00.7r1,1041,041829563r
Current liabilities4,7225,8854,2127,6975,9634,856r6,4686,0244,8673,657
Lease liabilities (non-current)209398596830—812r1,116———
Total liabilities4,9416,3384,8688,6666,2256,514r8,9236,7917,1553,673
Retained earnings5,71513,4346,7876,302−17,942−22,061r−15,226−13,526−11,503−7,792
Shareholders' equity48,09855,82748,84248,06926,01521,496r28,002r26,46011,68015,274
Total liabilities and equity53,03962,16553,71056,73532,24028,010r36,92533,25118,83518,947
Shares outstanding16161616171616161314
Cash-flow statement
Depreciation and amortization400200r275315613722r546658388338
Share-based compensation295323328187415386r621983406726
Cash from operating activities528−831−2,145−1,412−286−434r−2,107−8,564−3,057−851
Capital expenditure−196−276−229−159−128−359r−401−855−288−286
Cash from investing activities−196−276−18714,8411297,030r−4,898−2,6426,174−7,852
Shares bought back−300—−27−2,999——————
Cash from financing activities−30515−40−2,428−231211r2,62013,6051,9268,681
Change in cash——————−4,3842,3995,043−23
Report10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

What Sensus Healthcare, Inc. sells: revenue by product line, fiscal 2025#

As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.

Products and services

  • Product(total)$20 M72%
  • Service Revenue$3 M13%
  • Service(total)$3 M9.3%
  • Product Revenue$2 M6.3%

Countries and regions

Source: SEC annual report (XBRL data) · as of Dec 31, 2025

Where Sensus Healthcare, Inc. operates: 2 countries#

Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.

Sensus Healthcare, Inc.: countries of operation
CountryPresenceRevenue there
🇺🇸 USAHeadquarters1 office$25 M92%
🇨🇳 China$2 M7.4%

Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided

Events at Sensus Healthcare, Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

Warning signs in the last three years

  • Auditor changedFiling
  • Auditor changedFiling

Auditor changed 2 · Directors and officers 5 · Material agreement 1 · Shareholder vote 3 · Results announced 13

Sensus Healthcare, Inc.: events reported to the SEC
FiledWhat happenedFiling
Results announced8-K
Results announced8-K
Material agreement8-K
Shareholder vote8-K
Results announced8-K
Results announced8-K
Auditor changed8-K
Directors and officers8-K
Directors and officers8-K
Results announced8-K
Results announced8-K
Shareholder vote8-K
Results announced8-K
Results announced8-K
Results announced8-K
Results announced8-K
Auditor changed8-K
Results announced8-K
Shareholder vote8-K
Directors and officers8-K
Results announced8-K
Results announced8-K
Directors and officers8-K
Directors and officers8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Nov 12, 2026

Acquisitions and funding#

3 private funding rounds before listing

Private share sales · funding history

Private share sales of Sensus Healthcare, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2015$2 MNo. 3$2 to $10 million58equitySEC
Jan 2013$1 MNo. 2Under $2 million25equitySEC
Mar 2012$2 MNo. 1$2 to $10 million19equitySEC
Jun 2010$6 MIssued in a merger or acquisition$2 to $10 million37equitySEC

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

Lobbying by Sensus Healthcare, Inc.#

$120 K spent on lobbying the US Congress and federal agencies in 2025, most often on health issues.

Lobbying, 2025
$120 K
#1,203 among companies on value.today
Own lobbyists
No
only outside firms
Firms hired
2
in 2025
2026 so far
—
  • Health Issues6 reports

Lobbying firms hired in 2025

CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC $70 K · Brian Glackin & Associates LLC $50 K

Sensus Healthcare, Inc.: lobbying spending by year
YearSpendingOwn lobbyistsReports
2025$120 K—6
2020$80 K—2
2019$200 K—4

Source: Lobbying Disclosure Act reports (Form LD-2). Filed as “Sensus Healthcare”, “Capitol Advocacy & Government Affairs, LLC (On Behalf of Sensus Healthcare)” and “Sensus Healthcare, Inc.”. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero

Product recalls by Sensus Healthcare, Inc.#

1 recalls since 2015, 23 units in the notices that give a number. Medical devices (FDA): 1.

Sensus Healthcare, Inc.: product recalls
DateWhat and whyUnitsNotice
Sensus Healthcare Inc, SRT-100 Vision IPX 0, HFUS Module IPX 1, with software version 1.9.2; Superficial X-ray Radiation Therapy System with Ultrasonic Imaging CapabilitiesWhen the user pauses the beam delivery, the dose timer is reset (to zero), and as a result may deliver an unexpected dose to the patient.Medical devicesClass II23Z-1235-2023

Source: NHTSA, CPSC and FDA recall notices. Recalls filed under a subsidiary with a different name may be missing. The number of recalls says nothing about their seriousness

How Sensus Healthcare, Inc. compares in Medical Devices

  • Market cap$49 M · higher than 28% of 142
  • Revenue$27 M · higher than 22% of 155
  • Net margin-88.5% · higher than 16% of 144
  • Revenue growth-34.3% · higher than 4% of 104
  • Price / sales2.8× · lower than 52% of 96
  • Price / book1.0× · lower than 86% of 99
  • FCF yield0.7% · higher than 63% of 76

Peer comparison · Medical Devices

CompanyMarket capP/ENet marginRev. growth
Sensus Healthcare, Inc.🇺🇸$49 M—-88.5%-34.3%
Abbott Laboratories🇺🇸$181.1 B38.5×9.8%+5.7%
Medtronic plc🇺🇸$121.2 B23.2×13.9%+8.4%
Stryker Corporation🇺🇸$116.5 B32.2×13.8%+11.2%
Boston Scientific Corporation🇺🇸$66.2 B18.9×16.6%+19.9%
Edwards Lifesciences Corporation🇺🇸$52.8 B51.7×15.3%+11.6%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.🇨🇳$27.8 B23.6×24.4%—
STERIS plc🇮🇪$20.4 B24.6×13.4%+8.7%
Zimmer Biomet Holdings, Inc.🇺🇸$18.2 B23.8×8.9%+7.2%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Oct 1, 2026
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Employees:
As of December 31, 2025
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research, SEC annual report, GLEIF register; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Sensus Healthcare, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Sensus Healthcare, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Sensus Healthcare, Inc.? Suggest a correction